awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36671445-D820BEA3-A146-4C7A-B76A-4DCCBEED2BAE
Q36671445-D820BEA3-A146-4C7A-B76A-4DCCBEED2BAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36671445-D820BEA3-A146-4C7A-B76A-4DCCBEED2BAE
A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma
P2860
Q36671445-D820BEA3-A146-4C7A-B76A-4DCCBEED2BAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36671445-D820BEA3-A146-4C7A-B76A-4DCCBEED2BAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b574df58a7b3abad2d3ec28f64ef8d5f9ff47dde
P2860
Phase Ib dose-escalation study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma.